Subcutaneous injection of IHP-102 prevents lung vaso-occlusion in sickle cell disease mice

Haematologica. 2024 Apr 1;109(4):1259-1263. doi: 10.3324/haematol.2023.283716.
No abstract available

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Animals
  • Injections, Subcutaneous
  • Lung
  • Mice
  • Vascular Diseases*

Grants and funding

Funding: This study was supported by the sponsored research agreement with IHP Therapeutics and the NIH-NHLBI R44HL167473 to JP. PS was supported by NIH-NHLBI R01HL128297, R01HL141080, R01HL166345 and American Heart Association 18TPA34170588. RKD was supported by the Keystone Grant from the Histochemical Society. RV was supported by American Heart Association predoctoral fellowship 19PRE34430188. TWK was supported by American Heart Association postdoctoral fellowship AHA828786. TB was supported by American Society of Hematology (ASH) Research Restart Award. The Nikon multiphoton excitation microscopes were funded by NIH grants S10RR028478 and S10OD025041.